Get access

Treatment of atopic dermatitis in pregnancy

Authors


  • Conflict of Interest Information: Bruce Strober has been a principal investigator, an advisor or consultant, or a speaker for the following groups: Abbott, Amgen, Celgene, Janssen, Maruho, Novartis, Pfizer and UBC.

Address correspondence and reprint requests to: Bruce Strober, MD, PhD, Department of Dermatology, University of Connecticut School of Medicine, Farmington, CT 06032, or email: strober@uchc.edu

Abstract: 

Atopic dermatitis (AD), also referred to as eczema, is one of the most frequently observed skin diseases in pregnant patients. The presentation and histopathology of this condition during pregnancy is identical to that of the non-pregnant individual. AD is a T-helper 2 dominant disease and may worsen during pregnancy, which favors this population of T-lymphocytes. AD management during pregnancy requires special precautions to avoid harming the fetus. Herein is an exploration of the different options available for the treatment of the pregnant patient with AD. The management of concomitant bacterial and viral infections is also discussed.

Get access to the full text of this article

Ancillary